About 49 employees are affected, about 70% of its workforce, according to Athira Pharma, Inc.'s latest layoff filing, on September 17, 2024. As of November 15, 2026, Athira Pharma, Inc. has reported this one exit or restructuring plan to the SEC on Form 8-K under Item 2.05. No WARN notice under its name is on file in the states covered here (Form 8-K, September 17, 2024).
10 companies announced layoffs this week, 1 had other signals.
Companies cutting jobs this week. Before you unlock: the company, the number of employees and what is inside. After: every way we found to reach the company. No individual is named in a layoff.
| UPWORK, INC | announced layoffs | |
| PVH CORP. /DE/ | announced layoffs | |
| Battelle | filed a layoff notice for 15 employees | |
| TidalHealth Primary Care | filed a layoff notice for 5 employees | |
| Phunware, Inc. | announced layoffs |
Is this your company?
Owed money by them or selling to them? See the free Snapshot of Athira Pharma, Inc.
Free to see. No signup.
People from Athira Pharma, Inc. who say they are open to work
Only people who added themselves are listed here. Nobody is named because of a company announcement or a news story, and we have not checked what anyone says about themselves.
Loading the list…
Affected by the Athira Pharma, Inc. layoff? Add yourself to the open-to-work list, free
Your entry
Athira Pharma, Inc. reported 1 exit or restructuring plan on Form 8-K under Item 2.05, 1 of 1 stating how many employees or positions are affected. Each fact below is the filing's own sentence, quoted and linked. No WARN notice under this company's name is on file in the states covered here.
Did Athira Pharma have layoffs in 2024? What its filings say
Athira Pharma, Inc. (CIK 1620463) reported 1 exit or restructuring plan to the SEC on Form 8-K under Item 2.05. The sentences below are quoted from the filings as written.
Form 8-K filed 2024-09-17
Employees affected
On September 15, 2024, Athira Pharma, Inc. (the "Company") committed to a workforce reduction that is expected to result in the termination of approximately 49 positions, representing approximately 70% of the Company's workforce (the "Restructuring").
Expected charges
In connection with the Restructuring, the Company currently estimates it will incur one-time costs of approximately $2.8 million, consisting primarily of cash severance costs and termination benefits, which the Company expects to recognize in the third quarter of 2024.
Timing
The Company expects to substantially complete the Restructuring by December 31, 2024.
Also on the record for Athira Pharma, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| November 13, 2026 | Stake report, Schedule 13G, by Spruce Street Capital LP | 4.2% of the class | 5%+ stakes | Source |
| November 4, 2026 | Stake report, Schedule 13G, by Great Point Partners, LLC | 5.03% of the class | 5%+ stakes | Source |
| October 28, 2026 | Stake report, Schedule 13D/A, by Sermonix Pharmaceuticals, Inc. | 25.1% of the class | 5%+ stakes | Source |
| October 26, 2026 | Stake report, Schedule 13D/A, by Perceptive Advisors LLC | 19.99% of the class | 5%+ stakes | Source |
| August 31, 2026 | Stake report, Schedule 13D, by Sermonix Pharmaceuticals, Inc. | 36.9% of the class | 5%+ stakes | Source |
| August 25, 2026 | Stake report, Schedule 13D/A, by Perceptive Advisors LLC | 19.99% of the class | 5%+ stakes | Source |
| August 20, 2026 | Stake report, Schedule 13G/A, by Anders Hove | 12.1% of the class | 5%+ stakes | Source |
| May 15, 2026 | Stake report, Schedule 13G, by ADAR1 Capital Management, LLC | 7.7% of the class | 5%+ stakes | Source |
| May 7, 2026 | Stake report, Schedule 13D/A, by Perceptive Advisors LLC | 19.99% of the class | 5%+ stakes | Source |
| March 19, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
| February 6, 2026 | Stake report, Schedule 13G/A, by Baselake Partners, LP | 1.9% of the class | 5%+ stakes | Source |
| January 16, 2026 | Stake report, Schedule 13D/A, by Perceptive Advisors LLC | 19.99% of the class | 5%+ stakes | Source |
Keep reading
More on Athira Pharma, Inc. and the records around it.
Athira Pharma, Inc. elsewhere on the record
- 5%+ stake filings Nov 2026
- Who owns it
Companies that share a holder
- Oliveira Steven Michael also filed stake reports on 1 other company: Forte Biosciences, Inc. (Jan 2026)
- ACORN BIOVENTURES, L.P. also filed stake reports on 5 other companies: Karyopharm Therapeutics Inc. (Oct 2026), enGene Therapeutics Inc. (Jul 2026), OnKure Therapeutics, Inc. (Apr 2026)
- Spruce Street Capital LP also filed stake reports on 5 other companies: Entera Bio Ltd. (Nov 2026), Research Alliance Corp IV (Nov 2026), Yarrow Bioscience, Inc. (Nov 2026)
Watch Athira Pharma, Inc.
Get an email when Athira Pharma, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
What do you want to do with Athira Pharma, Inc.?
Want the whole picture on Athira Pharma, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Athira Pharma, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Athira Pharma, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
13 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
The newest 12 of 19 records.
Tools for this story
Each opens in a new tab, filled in for Athira Pharma, Inc.. With no account yet, you sign up free and land on the result.
Public companies must also report to the SEC, on Form 8-K under Item 2.05, when they commit to an exit or restructuring plan that will cost them material charges, which is how most large layoffs and closures by listed companies are disclosed. Those filings are national, so they cover companies in every state. Each sentence shown from one is quoted exactly and linked to the filing; where a filing does not state a figure, none is shown.
Where this comes from
Employers covered by the federal WARN Act, and by the stricter laws some states add, must give written notice before a mass layoff or a site closure. The state labor department publishes those notices. Every row here is one of them, taken from that state's own published file and linked to it, so each figure can be checked at the source.
A notice states the employer, the location, the number of employees affected, and when the layoff or closure takes effect. It does not state a reason, and neither does this page. Where a company also appears in SEC filings under the same name and in the same state, its recorded fundraising is shown alongside, as a matter of record rather than as an explanation. New Jersey and Pennsylvania list a notice under the month it was posted or received, not the day, so their notices show a month. Tennessee gives the county rather than the city.
Who owns LeonaBio, Inc.? Owners, funding and legal record
Cite this page
https://mentionfox.com/layoffs/athira-pharma